Regulatory headwinds amidst M&A boom in Irish life sciences
M&A deals are heating up in Ireland's life sciences sector. But can companies navigate the challenges with growing regulations and AI's impact?
PharmaLifeScience News
Eli Lilly will ‘build new way of doing science’ in UK amid 297m pledge to government
Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use AI and tech to transform the company.
READ MORE
Starboard-Pfizer battle strains Guggenheim’s relationship with drugmaker
Boutique adviser’s work for two former executives has threatened its lucrative ties to the vaccine maker
READ MORE
Evaxion’s AI-immunology platform shines in multiple clinical trials
Evaxionâs proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets.
READ MORE
.png)